Yan Rolland

Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial

Étienne Garin, Lambros Tselikas, Boris Guiu et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 568 citations

Open-label Phase 2, Radiation Therapy, Medicine +8

Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.

Gilles Edan, David Miller, M. Clanet et al. · Journal of Neurology Neurosurgery & Psychiatry · 1997 · 422 citations · Full text

Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma

Julien Edeline, Yann Touchefeu, Boris Guiu et al. · JAMA Oncology · 2019 · 277 citations · Full text

Dosimetry Based on ^99mTc-Macroaggregated Albumin SPECT/CT Accurately Predicts Tumor Response and Survival in Hepatocellular Carcinoma Patients Treated with ⁹⁰Y-Loaded Glass Microspheres: Preliminary Results

Étienne Garin, Laurence Lenoir, Yan Rolland et al. · Journal of Nuclear Medicine · 2012 · 273 citations · Full text

Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma

Julien Edeline, Éveline Boucher, Yan Rolland et al. · Cancer · 2011 · 271 citations · Full text